Endothelial Effects of High-Density Lipoprotein (HDL) Remain Impaired Following Dalcetrapib Treatment in Patients with Coronary Artery Disease or Risk Equivalent

被引：0

作者：

Riwanto, Meliana ^{[1
]}

Deanfield, John ^{[2
]}

Manz, Jasmin ^{[3
]}

Rohrer, Lucia ^{[4
]}

Suchankova, Gabriela ^{[5
]}

Kallend, David ^{[5
]}

von Eckardstein, Arnold ^{[4
]}

Luscher, Thomas F. ^{[1
]}

Landmesser, Ulf ^{[1
]}

机构：

[1] Univ Zurich Hosp, Dept Cardiol, Cardiovasc Cntr, CH-8091 Zurich, Switzerland

[2] UCL, Vasc Physiol Unit, London, England

[3] Univ Zurich, Inst Physiol, Zurich, Switzerland

[4] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland

[5] F Hoffmann La Roche & Co Ltd, Clin Dev, CH-4002 Basel, Switzerland

来源：

关键词：

HDL elevating therapies; Endothelial function; Coronary artery disease; Nitric oxide;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

18661

引用

页数：2